Elvina Almuradova/LinkedIn
Jan 17, 2025, 22:36
Elvina Almuradova: FDA has granted Fast Track designation to LOAd703 for pancreatic cancer
Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, shared a post on X:
“FDA has granted Fast Track designation to LOAd703 for pancreatic cancer!
94% of patients showed immune activation, and 44% achieved an objective response in phase 1/2 trials. Safe dosing was established with manageable side effects.”
More posts featuring Elvina Almuradova.
Elvina Almuradova is the Oncology Unit Lead at Can Hospitals Turkey and an Ambassador for the European School of Oncology. Previously, she was an Associate Professor of Oncology at the European Institute of Oncology (IEO). Her expertise encompasses basic oncology, chemotherapy, cancer biomarkers, diagnostics, and cancer cell biology.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 10, 2025, 12:19
Jun 10, 2025, 12:16
Jun 10, 2025, 11:37